1. Home
  2. CORT vs DLB Comparison

CORT vs DLB Comparison

Compare CORT & DLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corcept Therapeutics Incorporated

CORT

Corcept Therapeutics Incorporated

HOLD

Current Price

$88.23

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Logo Dolby Laboratories

DLB

Dolby Laboratories

HOLD

Current Price

$67.61

Market Cap

6.4B

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
CORT
DLB
Founded
1998
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
7.6B
6.4B
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
CORT
DLB
Price
$88.23
$67.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$139.00
$93.60
AVG Volume (30 Days)
663.7K
653.1K
Earning Date
11-04-2025
01-28-2026
Dividend Yield
N/A
2.13%
EPS Growth
N/A
N/A
EPS
0.87
2.62
Revenue
$741,172,000.00
$1,349,130,000.00
Revenue This Year
$23.79
$5.03
Revenue Next Year
$40.97
$4.02
P/E Ratio
$99.75
$25.82
Revenue Growth
17.92
5.92
52 Week Low
$49.00
$64.02
52 Week High
$117.33
$89.66

Technical Indicators

Market Signals
Indicator
CORT
DLB
Relative Strength Index (RSI) 68.54 53.05
Support Level $81.31 $66.09
Resistance Level $87.19 $68.84
Average True Range (ATR) 2.86 1.17
MACD 0.74 0.22
Stochastic Oscillator 93.81 52.04

Price Performance

Historical Comparison
CORT
DLB

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About DLB Dolby Laboratories

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

Share on Social Networks: